Chantal Quinten, PhD

Scientific Administrator
European Medicines Agency, Netherlands

Poster(s):

• (277) A Methodology Study to Evaluate External Comparator Arm Study Results Versus Randomised Controlled Trial Results: Multiple Myeloma Case Study
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST

• (W) Benefit Risk Contextualisation of COVID-19 Vaccines in the EU
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (259) Getting Prepared for COVID-19 Vaccines: How European Regulators Anticipated the Need for Real-World Evidence
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (104) Impact of Angiotensin-Receptor-Blocker (ARB) Recalls Due to Nitrosamine Contamination on ARB Utilization in Germany: A Multinational Study with a Common Protocol Led by FDA
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (166) MINERVA: Metadata for Data Discoverability and Study Replicability in Observational Studies
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (121) Prescribing Patterns of Codeine and Alternatives in Children Across Five EEA Countries Between 2010 and 2017
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST